M. Frechette

Récents

• Complex karyotype AML displays G2/M signature and hypersensitivity to PLK1 inhibition
• Mubritinib Targets the Electron Transport Chain Complex I and Reveals the Landscape of OXPHOS Dependency in Acute Myeloid Leukemia